1. 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. (10th December 2020) Authors: Shah, Nina; Tan, Alan; Budde, Lihua; Hofmeister, Craig; Cowan, Andrew; Saeed, Hayder; Ye, Jing; Cairo, Mitchell; Rizzieri, David; Orloff, Gregory; Ge, Xue Snow; Lee, Zachary; Dixit, Neha; Nieves, Wildaliz; Vimal, Mona; Ma, Haijun; Miyazaki, Takahiro; Madakamutil, Loui; Marcondes, Mario; Lin, Wei Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 368 REVEAL: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: local innate immune activation and systemic adaptive immune expansion for treating solid tumors. (10th December 2020) Authors: Diab, Adi; Curti, Brendan; Bilen, Mehmet; Brohl, Andrew; Domingo-Musibay, Evidio; Borazanci, Erkut; Fanton, Christie; Haglund, Cat; Vimal, Mona; Muhsin, Mann; Marcondes, Mario; Nguyen, Anh; Tagliaferri, Mary; Lin, Wei; Zalevsky, Jonathan; D'Angelo, Sandra Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 368 REVEAL: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: local innate immune activation and systemic adaptive immune expansion for treating solid tumors. (9th November 2020) Authors: Diab, Adi; Curti, Brendan; Bilen, Mehmet; Brohl, Andrew; Domingo-Musibay, Evidio; Borazanci, Erkut; Fanton, Christie; Haglund, Cat; Vimal, Mona; Muhsin, Mann; Marcondes, Mario; Nguyen, Anh; Tagliaferri, Mary; Lin, Wei; Zalevsky, Jonathan; D'Angelo, Sandra Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗